IMMUNIC, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for IMMUNIC, INC. (IMUX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are IMUX insiders buying or selling?
IMMUNIC, INC. insiders reported no open-market purchases or sales in the last 12 months. Since September 2018, Trabud has recorded 37 Form 4 filings for IMUX: 27 buys ($927.4K) and 10 sells ($4.5M).
Source: SEC EDGAR Form 4
Key Statistics (September 2018 – Jun 20, 2025)
Total Form 4 filings
37
SEC EDGAR
Insider filers
14
Insider buys (27)
$927.4K
Insider sells (10)
$4.5M
Insider sentiment
Net sellingNet insider flow of $3.6M in net selling since September 2018.
Recent IMUX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Jason Tardio | President and COO | Purchase | 12.5K | $0.79 | $9.9K | SEC ↗ |
| Jun 20, 2025 | Daniel Vitt | CEO and Director | Purchase | 15.0K | $0.77 | $11.6K | SEC ↗ |
| Jun 16, 2025 | Duane Nash | Executive Chairman | Purchase | 20.0K | $0.83 | $16.7K | SEC ↗ |
| Jun 9, 2025 | Jason Tardio | President and COO | Purchase | 12.5K | $0.79 | $9.9K | SEC ↗ |
| Jun 6, 2025 | Daniel Vitt | CEO and Director | Purchase | 15.0K | $0.77 | $11.6K | SEC ↗ |
| Jun 5, 2025 | Joerg Neermann | Director | Purchase | 100.0K | $0.77 | $76.7K | SEC ↗ |
| Jun 4, 2025 | Glenn Whaley | Chief Financial Officer | Purchase | 45.0K | $0.71 | $32.1K | SEC ↗ |
| Jun 4, 2025 | Richard Alan Rudick | Director | Purchase | 143.1K | $0.70 | $100.0K | SEC ↗ |
| Nov 13, 2024 | Richard Alan Rudick | Director | Purchase | 87.3K | $1.15 | $100.4K | SEC ↗ |
| Feb 28, 2024 | Daniel Vitt | President and CEO | Purchase | 14.0K | $1.31 | $18.3K | SEC ↗ |
| May 16, 2023 | Glenn Whaley | Chief Financial Officer | Purchase | 5.0K | $1.75 | $8.8K | SEC ↗ |
| Dec 15, 2022 | Joerg Neermann | Director | Purchase | 82.0K | $1.25 | $102.6K | SEC ↗ |
| Nov 25, 2022 | Joerg Neermann | Director | Purchase | 18.0K | $1.39 | $25.0K | SEC ↗ |
| Nov 23, 2022 | Daniel Vitt | President and CEO | Purchase | 8.0K | $1.35 | $10.8K | SEC ↗ |
| Nov 8, 2022 | Glenn Whaley | Chief Financial Officer | Purchase | 5.0K | $1.50 | $7.5K | SEC ↗ |
| Jun 6, 2022 | Daniel Vitt | President and CEO | Purchase | 5.0K | $3.10 | $15.5K | SEC ↗ |
| Jun 6, 2022 | Glenn Whaley | Chief Financial Officer | Purchase | 3.5K | $3.05 | $10.7K | SEC ↗ |
| May 16, 2022 | Andreas Muehler | Chief Medical Officer | Purchase | 3.5K | $5.10 | $17.9K | SEC ↗ |
| May 13, 2022 | Glenn Whaley | Chief Financial Officer | Purchase | 3.0K | $5.08 | $15.2K | SEC ↗ |
| May 13, 2022 | Duane Nash | Executive Chairman | Purchase | 10.0K | $5.03 | $50.3K | SEC ↗ |
| Aug 11, 2021 | Glenn Whaley | PFO and PAO | Purchase | 1.5K | $9.85 | $14.8K | SEC ↗ |
| Aug 11, 2021 | Daniel Vitt | President and CEO | Purchase | 1.0K | $9.60 | $9.6K | SEC ↗ |
| Aug 11, 2021 | Duane Nash | Executive Chairman | Purchase | 1.0K | $9.80 | $9.8K | SEC ↗ |
| May 12, 2021 | Duane Nash | Executive Chairman | Purchase | 4.0K | $12.75 | $51.0K | SEC ↗ |
| Mar 15, 2021 | Andreas Muehler | Chief Medical Officer | Purchase | 10.0K | $15.54 | $155.5K | SEC ↗ |
Showing the 25 most recent of 37 Form 4 filings for IMMUNIC, INC..
Most active IMUX insiders
- Glenn Whaley8 filings
- Daniel Vitt7 filings
- Duane Nash5 filings
- Joerg Neermann3 filings
- Andreas Muehler2 filings
Ask anything about IMUX insider activity
Use Trabud's AI agent to query IMMUNIC, INC.'s Form 4 history in plain English — "Show me IMUX CEO purchases this year" or compare it against any other ticker.
Open the AI agentIMUX insider trading FAQ
Are IMMUNIC, INC. insiders buying or selling?
IMMUNIC, INC. insiders reported no open-market purchases or sales in the last 12 months. Since September 2018, Trabud has recorded 37 Form 4 filings for IMUX: 27 buys ($927.4K) and 10 sells ($4.5M). Over the full record that is net selling of $3.6M.
How many insiders trade IMUX stock?
14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for IMMUNIC, INC.. The most recent filing was accepted on Jun 20, 2025.
Where does Trabud get IMUX insider trading data?
All IMUX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.